Objective: Urinary cytology is a key diagnostic tool for evaluating suspected urinary tract carcinoma, primarily high-grade urothelial carcinoma. The Paris System for Reporting Urinary Cytology (TPS), introduced in 2016, aimed to standardize reporting, though challenges with subjectivity and variability in diagnosing Atypical Urothelial Cells (AUCs) persist.
Methods: This retrospective study explored the correlation between cytomorphological features in "atypical" diagnosis and UroVysion fluorescence hybridization (U-FISH) results. We assessed 19 cytomorphologic parameters in 121 cases. Histologic diagnosis, clinical findings, and patient history were also documented.
Results: Of 121 cases, 38 (31.4%) tested U-FISH positive. The sensitivity and specificity of U-FISH in detecting malignancy were 93.5% and 91.1%, respectively. Five cytologic parameters-high atypical cellularity, nuclear/cytoplasmic ratio ≥0.7, nuclear enlargement (≥2.5 times), multinucleation, and mitosis-were significantly associated with U-FISH positivity. No association was found between TPS AUC criteria and U-FISH positivity. The majority of combinations of these key parameters exhibited high PPVs (>65.0%), suggesting their potential for classifying cases without U-FISH.
Conclusions: Cases exhibiting combinations of these five parameters or any four including mitosis demonstrated a 100% positive predictive value (PPV). However, subsets of cases with certain parameter combinations showed moderate PPVs, indicating the potential utility of reflex U-FISH testing.
Download full-text PDF |
Source |
---|
Ann Clin Lab Sci
November 2024
Department of Pathology and Translational Pathobiology, Louisiana State University Health Sciences Center, Shreveport, LA, USA
Objective: Urinary cytology is a key diagnostic tool for evaluating suspected urinary tract carcinoma, primarily high-grade urothelial carcinoma. The Paris System for Reporting Urinary Cytology (TPS), introduced in 2016, aimed to standardize reporting, though challenges with subjectivity and variability in diagnosing Atypical Urothelial Cells (AUCs) persist.
Methods: This retrospective study explored the correlation between cytomorphological features in "atypical" diagnosis and UroVysion fluorescence hybridization (U-FISH) results.
J Clin Med
October 2024
Division of Gastroenterology and Hepatology, Mayo Clinic, 200, First St SW, Rochester, MN 55905, USA.
Cytopathology
October 2024
Department of Pathology, Michigan Medicine, Ann Arbor, Michigan, USA.
Introduction/objective: Biliary brushing cytology (BB) to detect cholangiocarcinoma (CCA) is integral in the surveillance of patients with primary sclerosing cholangitis (PSC). Since reactive changes can mimic carcinoma, indeterminant results are frequent. Fluorescence in situ hybridization (FISH) using the UroVysion probe set has been advocated to enhance the detection of CCA.
View Article and Find Full Text PDFActa Cytol
November 2024
Department of Urology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Introduction: The atypical urothelial cell (AUC) category in The Paris System (TPS) in urine cytology (UrCy) is a challenging area. This study aimed to evaluate the UroVysion fluorescence in situ hybridization (U-FISH) assay in predicting the outcome of AUC. Additionally, we explored the association of abnormal U-FISH results in high-grade urothelial carcinoma (HGUC) concerning muscularis propria invasion (MPI).
View Article and Find Full Text PDFBJUI Compass
May 2024
Acupath Laboratories Inc Plainview New York USA.
Objective: This study evaluates the efficacy of Acu-URO17, a highly sensitive and specific immunocytochemistry (ICC) test targeting Keratin 17, in comparison to urine cytology and UroVysion™ fluorescence in situ hybridization (FISH) for detecting bladder cancer cells in voided urine specimens.
Methods: Acupath conducted a large-scale comparison study using 2378 voided urine specimens. Acu-URO17, urine cytology and UroVysion™ FISH were performed on these specimens according to standardized protocols.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!